The global market for
cancer pain therapeutics is expected to post a healthy market growth rate of more than 9% during the forecast period.
Most of the world's population lacks the necessary access to opioids for
cancer pain management and palliative care.
When one considers that effective treatments are cheap and available, untreated
cancer pain and its horrendous consequences for patients and their families is a scandal of global proportions," Cherny says.
Still, the evidence is growing that pain is a multisystemic, multifactorial challenge, felt more acutely in the face of fear or stress, so the wise guidance of those who treat "Dueling Diagnoses" will add value to the treatment of
cancer pain, even in the most straightforward of cases.
Abstral is a rapidly disintegrating tablet for sublingual (under the tongue) administration of fentanyl intended for the management of breakthrough pain in cancer patients who are already receiving opioid analgesics for their underlying persistent
cancer pain.
The panel urges the public and the health professions to be aware that appropriate pain relief - including narcotics in adequate dosages - is a right of patients with
cancer pain.
The Pharmacor report entitled
Cancer Pain finds that the product development pipeline for
cancer pain therapies is dominated by potential treatments for severe
cancer pain as most of these drugs are reformulated long-acting opioid analgesics.
The story of Otis' relief from
cancer pain is well documented in a video accessible at www.
Today, the results from a European Survey of Oncology Nurse Breakthrough
Cancer Pain Practices were presented for the first time at The European Multidisciplinary Cancer Congress in Stockholm.
Abstral is a rapidly-disintegrating tablet for sublingual (under the tongue) administration of fentanyl intended for the management of breakthrough pain in cancer patients who are already receiving opioid analgesics for their underlying persistent
cancer pain.
Abstral is a sublingual (under the tongue) tablet for the fast administration of fentanyl, an opioid commonly used to treat breakthrough
cancer pain in patients who are already receiving opioid analgesics.
Chapters are well arranged into discrete sections pertaining to 1) general considerations, 2)
cancer pain relating to tumour extension, 3)
cancer pain resulting from therapy, 4) multidisciplinary approaches, 5) pharmacological management, 6) non-pharmacological management, 7) interventional techniques and 8) palliative care.
